Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

ACA replacement—just not repeal—may find Democratic support

Repealing the Affordable Care Act (ACA) can be passed with only Republican votes soon after President-elect Donald Trump takes office. Replacing the law, however, can’t be done by one party.

White House report defends ACA as ‘historic progress’

A report on the “economic record” of the Obama Administration’s healthcare reforms credited the Affordable Care Act (ACA) for lower uninsured rates, increased access to care and slowed growth in healthcare spending.

HHS Secretary: Healthcare reform must ‘continue to endure’

HHS Secretary Sylvia Burwell defended the Affordable Care Act (ACA) and the broader efforts of changing healthcare payments, delivery systems and health IT in a Health Affairs blog post.

Aura Labs settles with FTC for inaccurate blood pressure app

Aura Labs has agreed to settle charges from the Federal Trade Commission (FTC) relating to its Instant Blood Pressure (IBP) mobile application, which came under fire for claims that is was as effective as a conventional blood pressure cuff.

52 million with pre-existing conditions could be denied coverage if ACA repealed

If pre-Affordable Care Act (ACA) health insurance regulations returned with a repeal of the law, 52 million people under the age of 65—27 percent of the U.S. population—could be denied coverage on the individual market due to pre-existing conditions.

Physicians likely to have an ally in Tom Price at HHS

The nominee to run HHS under President-elect Donald Trump has a history of putting doctors’ interests first.

‘Dramatic slowdown’ in value-based care transition—and how Congress can jumpstart it

Members of the American Medical Group Association (AMGA) reported the transition to value-based care is slower than expected, with more multispecialty medical groups and integrated systems predicting fee-for-service (FFS) payments will take up a greater percentage of revenues in the next few years than originally projected.

Medicaid expansion in New York now covers transgender healthcare

Youths in New York are now covered by Medicaid to receive gender-transition care, according to a recent report from the Wall Street Journal.

Displaying 2145 - 2152 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup